AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES Share Price

Certificat

DE000VD2T627

Real-time Bid/Ask 02:38:08 23/05/2024 pm IST
102.4 EUR / 103.9 EUR +0.70% Intraday chart for AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES
Current month+3.88%
1 month+6.62%
Date Price Change
23/24/23 102.4 -0.02%
22/24/22 102.4 0.00%
21/24/21 102.4 +0.22%
20/24/20 102.2 +0.34%
17/24/17 101.9 -0.70%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 12:02 pm IST

More quotes

Static data

Product typeObligations Convertibles
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Vontobel Vontobel
WKN VD2T62
ISINDE000VD2T627
Date issued 26/03/2024
Strike 13 $
Maturity 21/03/2025 (303 Days)
Parity 0.01 : 1
Emission price 100
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 103
Lowest since issue 94.84
Spread 15.1
Spread %1.45%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.88 USD
Average target price
17.34 USD
Spread / Average Target
+2.70%
Consensus